EP3837256
Úrea-efnasambönd og samsetningar sem SMARCA2/BRM-ATPasa hindrar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.8.2019EP published:
8.3.2023EP application number:
19779145.2
EP translation filed:
22.5.2023Grant published:
15.6.2023EPO information:
European Patent Register
Max expiry date:
11.8.2039Expiry date:
11.8.2025
Title in English:
UREA COMPOUNDS AND COMPOSITIONS AS SMARCA2/BRM-ATPASE INHIBITORSLanguage of the patent:
English
Timeline
Today
12.8.2019EP application
8.3.2023EP Publication
22.5.2023Translation submitted
15.6.2023Registration published
11.8.2025Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
ADAIR, ChristopherAddress:
Brighton, Massachusetts 02135, US
Name:
PAPILLON, JulienAddress:
Cambridge, Massachusetts 02139, US
Name:
NAKAJIMA, KatsumasaAddress:
Cambridge, Massachusetts 02139, US
Name:
SMITH, Troy DouglasAddress:
Cambridge, Massachusetts 02139, US
Name:
NTAGANDA, RukundoAddress:
Cambridge, Massachusetts 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862765138 PDate:
17.8.2018Country:
US
Classification
Categories:
C07D 417/12, A61P 35/00, A61K 31/4439
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 26.7.2023
Expires: 11.8.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 23.7.2024
Expires: 11.8.2025
Payer: Árnason Faktor ehf.